Likewise, inhibition of mTOR after rapamycin treatment of MCF‐7 breast cancer cells leads to increased AMPK activation, indicating a reciprocal relation between these energy‐sensing pathways (Zakikhani et al., 2010). The gene discussed is MTOR; the disease is breast carcinoma.